Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Noritaka Takatsu"'
Autor:
Ken Kinjo, Toshiyuki Matsui, Takashi Hisabe, Hiroshi Ishihara, Toshiki Kojima, Kenta Chuman, Shigeyoshi Yasukawa, Tsuyoshi Beppu, Akihiro Koga, Satoshi Ishikawa, Masahiro Kishi, Noritaka Takatsu, Fumihito Hirai, Kenshi Yao, Toshiharu Ueki, Masakazu Washio
Publikováno v:
Intestinal Research, Vol 16, Iss 3, Pp 458-466 (2018)
Background/AimsColonic diverticular hemorrhage (DH) was a rare disease until the 1990s, and its incidence has increased rapidly since 2000 in Japan. In recent years, colonic DH has been the most frequent cause of lower gastrointestinal bleeding (LGIB
Externí odkaz:
https://doaj.org/article/0ee3b11bfd734176ac5857a347251214
Autor:
Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh
Publikováno v:
Intestinal Research, Vol 16, Iss 2, Pp 223-232 (2018)
Background/AimsDecreased trough levels of infliximab (TLI) and antibodies to infliximab (ATI) are associated with loss of response (LOR) in Crohn's disease. Two prospective studies were conducted to determine whether TLI or ATI better correlates with
Externí odkaz:
https://doaj.org/article/b4f642de10754961b41fd5f4fe788d0a
Autor:
Daisuke Saito, Fumihito Hirai, Kazuhiko Uchiyama, Tomohisa Takagi, Yuji Naito, Noritaka Takatsu, Hiroshi Tanabe, Mitsuo Kishimoto, Minoru Matsuura, Jun Miyoshi, Kenji Watanabe, Motohiro Esaki, Makoto Naganuma, Tadakazu Hisamatsu
Publikováno v:
Endoscopy International Open. 11:E504-E512
Background and study aims An important therapeutic aim in ulcerative colitis (UC) is endoscopic remission. Although an endoscopic score with white light imaging (WLI) is mainly used to evaluate endoscopic findings, the usefulness of linked color imag
Autor:
Noritaka Takatsu, Takashi Hisabe, Masahiro Kishi, Teruyuki Takeda, Shigeyoshi Yasukawa, Akihiro Koga, Ken Kinjo, Fumihito Hirai, Toshiharu Ueki, Kenshi Yao
Publikováno v:
Journal of Gastroenterology and Hepatology. 38:52-60
The short-term efficacy of tacrolimus (Tac) for steroid-dependent and steroid-resistant refractory ulcerative colitis (UC) has been demonstrated; however, its long-term outcomes have not been well documented. Thus, this study aimed to clarify the lon
Publikováno v:
Journal of Crohn's and Colitis.
Background and Aims Perianal lesion is a refractory phenotype of Crohn’s disease [CD] with significantly diminished quality of life. We evaluated the clinical characteristics of perianal lesions in newly diagnosed CD patients and the impact of peri
Autor:
Masahiro Kishi, Fumihito Hirai, Noritaka Takatsu, Takashi Hisabe, Yasumichi Takada, Tsuyoshi Beppu, Ken Takeuchi, Makoto Naganuma, Kazuo Ohtsuka, Kenji Watanabe, Takayuki Matsumoto, Motohiro Esaki, Kazutaka Koganei, Akira Sugita, Keisuke Hata, Kitarou Futami, Yoichi Ajioka, Hiroshi Tanabe, Akinori Iwashita, Hirotaka Shimizu, Katsuhiro Arai, Yasuo Suzuki, Tadakazu Hisamatsu
Publikováno v:
Journal of Gastroenterology. 57:246-266
Many clinical trials have been conducted for inflammatory bowel disease (IBD), so various clinical indices (CIs) and endoscopic indices (EIs) have also been evaluated. However, recently, with the progress of IBD management, review of established indi
Autor:
Ryuichiro Maekawa, Suketo So, Soichi Itaba, Hyonji Kim, Masahiro Yamasaki, Michihiko Shibata, Tatsuyuki Watanabe, Keiichiro Kume, Yasuhiro Takaki, Shinsuke Kumei, Noritaka Takatsu, Shigeo Nakamura, Ryosuke Sakemi, Masaru Harada, Hirotada Akiho, Toshihiro Sakurai, Ichiro Yoshikawa
Publikováno v:
Internal Medicine
Objective Real-world data of adalimumab (ADA) in the treatment of ulcerative colitis (UC) are scarce. We aimed to study the ADA response rates and predictors of response in UC treatment. Methods This observational, prospective and multi-center study
Autor:
Masaki Miyaoka, Kenshi Yao, Teruyuki Takeda, Tsuyoshi Beppu, Fumihito Hirai, Toshiharu Ueki, Noritaka Takatsu, Hisatomi Arima, Yasumichi Takada, Masahiro Kishi, Takashi Hisabe
Publikováno v:
Digestive Endoscopy. 34:517-525
BACKGROUND AND AIMS Efficacy of endoscopic balloon dilation (EBD) for intestinal strictures in patients with Crohn's disease (CD) receiving anti-tumor necrosis factor alpha antibodies (anti-TNF) as maintenance therapy is unclear. We investigated the
Autor:
Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Kenji Watanabe, Hisashi Shiga, Noritaka Takatsu, Shigeki Bamba, Yohei Mikami, Takayuki Yamamoto, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu, Taku Kobayashi, Naoki Ohmiya, Masayuki Saruta, Koichiro Matsuda, Takayuki Matsumoto, Hiroshi Nakase, Atsuo Maemoto, Shinichiro Shinzaki, Yoko Murata, Shinichi Yoshigoe, Ayako Sasaki, Tsutomu Yajima, Tadakazu Hisamatsu
Publikováno v:
Journal of gastroenterology. 57(11)
The Inception Cohort Registry Study of Patients with Crohn's Disease aimed to clarify clinical characteristics and disease course of newly diagnosed Crohn's disease patients in Japan throughout a 4-year period. Results from an interim analysis of the
Publikováno v:
Core Evidence. 15:7-20
Introduction Selective blockade of the integrins and mucosal adhesion molecules is a promising therapeutic strategy for ulcerative colitis (UC). Vedolizumab (VDZ), a humanized IgG1 monoclonal antibody against α4β7 integrin, selectively blocks the t